BFC Planning’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BFC Planning's MDGL Position: Q3 2026 in Review
BFC Planning held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2026 at 19 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2405.
BFC Planning first reported a position in MDGL in Q3 2024 and has held it in 9 quarters since. The position peaked at $13.4K in Q4 2025. 340 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- BFC Planning held 19 shares of Madrigal Pharmaceuticals worth $9.6K as of Q3 2026.
- BFC Planning left its Madrigal Pharmaceuticals share count unchanged in Q3 2026.
- Madrigal Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2405 holding.
- BFC Planning first reported a position in Madrigal Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Madrigal Pharmaceuticals position peaked at $13.4K in Q4 2025.
- 340 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.